Thomas Flaten
Stock Analyst at Lake Street
(0.93)
# 2223
Out of 5,372 analysts
46
Total ratings
40.00%
Success rate
8.10%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OCX OncoCyte | Maintains: Strong Buy | 5 8 | 3.12 | 156.41% | 6 | May 21, 2025 | |
BDSX Biodesix | Maintains: Buy | 3 2 | n/a | n/a | 1 | May 14, 2025 | |
CSTL Castle Biosciences | Maintains: Buy | 40 35 | 18.5 | 89.19% | 6 | May 6, 2025 | |
OPTN OptiNose | Downgrades: Hold | 17 9 | n/a | n/a | 5 | Mar 20, 2025 | |
CKPT Checkpoint Therapeut... | Downgrades: Hold | 7 5 | n/a | n/a | 5 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 3.5 | 128.57% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 6 | 2.23 | 169.06% | 2 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 9 | 6.47 | 39.1% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 6.6 | 36.36% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.65 | 361.54% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 3.04 | 261.84% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 21.91 | 14.1% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 2.08 | 69130.77% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 3.6 | 122.22% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |